Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Financial Results
US firm ImmuCell has seen steady sales growth in the third quarter of 2018, despite a "down dairy economy".
US firm Zomedica Pharmaceuticals has seen its net loss in the third quarter of 2018 decrease.
UK firm Benchmark has recorded a 7% improvement in annual revenues, with its burgeoning genetics business offering one pillar of growth.
Bayer said its animal health division was considerably down by 15% in the third quarter "as expected".
Kindred Biosciences has reported its first quarterly revenues from its feline weight loss product Mirataz.
Phibro Animal Health's total revenues during the first quarter of fiscal 2019 climbed 3.5% to $200.2 million.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.